Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
34.20
-1.05 (-2.98%)
Jul 30, 2025, 5:35 PM CET

Dermapharm Holding SE Company Description

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business.

It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals.

The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology.

In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand.

It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands.

The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Dermapharm Holding SE
CountryGermany
Founded1991
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees3,610
CEOHans-Georg Feldmeier

Contact Details

Address:
Lil-Dagover-Ring 7
Grünwald, 82031
Germany
Phone49 89 6 41 86 0
Websiteir.dermapharm.de

Stock Details

Ticker SymbolDMP
ExchangeDeutsche Börse Xetra
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberDE000A2GS5D8
SIC Code2834

Key Executives

NamePosition
Dr. Hans-Georg FeldmeierChief Executive Officer and Chairman of the Management Board
Christof DreibholzChief Financial Officer, Chief Compliance Officer and Member of Management Board
Dr. Andreas EberhornChief Marketing Officer and Member of Management Board
Britta HambergerHead of Investor Relations and Corporate Communications